Description
A prescription medication (Mounjaro, Zepbound) that acts as a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist (GLP-2).
Benefits:
Used for managing type 2 diabetes and chronic weight management. Its dual-agonist action offers enhanced blood sugar control and weight reduction compared to single-action GLP-1 medications.
Under no circumstances should any products be used without the express direction of a licensed physician.
For research puposes only. We do not promote the personal use of these products.









There are no reviews yet.